Second‐trimester multimetabolite panel for early preeclampsia rule‐out
International Journal of Gynecology & Obstetrics · 2026-09 · 174 (3) · 1644-1654
DOI: 10.1002/ijgo.70983 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 31.03.2026. Verfasst von Matthews Silva Martins und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitoria, ES, Brazil. Hauptthemen laut MEDLINE: Pre-Eclampsia, Metabolomics, Pregnancy Trimester, Second. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, National Institute of Science and Technology (INCT) program in Physical (In)Activity and Health.
Abstract (Originalsprache)
Objective
We aimed to establish a high‐sensitivity, multimetabolite rule‐out model for the development of preeclampsia (PE), prioritizing minimizing false negatives to exclude low‐risk individuals from intensive surveillance confidently.
Methods
In this prospective, nested case–control study, maternal serum samples were collected between 20 +0 and 25 +6 weeks of gestation, before the diagnosis of PE, from the BRISA (Brazilian Ribeirão Preto and São Luís) prenatal cohort. Participants were prospectively followed until delivery, and PE cases were diagnosed during follow‐up. Among 1400 enrolled women, 940 delivered at our institution; 30 were later diagnosed with PE, and 28 were included in the metabolomics analysis. The control group encompassed 28 healthy women, matched for maternal age and body mass index. A targeted metabolomics approach analyzed a 41‐metabolite panel using liquid chromatography coupled with tandem mass spectrometry. Eight metabolites below the detection limit in ≥15% of samples were excluded.
Results
Compared to the control group, univariate analysis revealed lower methionine and glutamine concentrations and elevated threonine levels in the case group. Classification models based on the remaining 33 metabolites, using leave‐one‐out cross‐validation, achieved 100% sensitivity but had limited specificity (21%). A reduced four‐metabolite model maintained 100% sensitivity with 50% specificity, while our refined, best‐performing six‐metabolite model achieved 100% sensitivity and 61% specificity with a negative predictive value of 100%.
Conclusion
Our models demonstrated considerable potential as diagnostic tools for ruling out PE, thereby reinforcing their future applicability in screening and monitoring strategies during gestation to improve clinical decision‐making and alleviate the burden on healthcare systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiological Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitoria, ES, Brazil.
- Department of Biophysics and Pharmacology, Institute of Biosciences of Botucatu, São Paulo State University, Botucatu, SP, Brazil.
- School of Physical Education and Sport, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.
- Department of Childcare and Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
- Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
ORCID-Profile: Julyane N S Kaihara, Valeria Cristina Sandrim
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- National Institute of Science and Technology (INCT) program in Physical (In)Activity and Health
Zitieren
APA
Martins, M. S., Kaihara, J. N. S., Salgueiro, D. F., Cardoso, V. C., Quintana, S. M., Cavalli, R. C., Barauna, V. G., & Sandrim, V. C. (2026). Second‐trimester multimetabolite panel for early preeclampsia rule‐out. International Journal of Gynecology & Obstetrics, 174(3), 1644-1654. https://doi.org/10.1002/ijgo.70983
Vancouver
Martins MS, Kaihara JNS, Salgueiro DF, Cardoso VC, Quintana SM, Cavalli RC, et al. Second‐trimester multimetabolite panel for early preeclampsia rule‐out. International Journal of Gynecology & Obstetrics. 2026;174(3):1644-1654. doi:10.1002/ijgo.70983
BibTeX
@article{Martins2026,
author = {Martins, Matthews Silva and Kaihara, Julyane N S and Salgueiro, Diego Fortes and Cardoso, Viviane Cunha and Quintana, Silvana Maria and Cavalli, Ricardo Carvalho and Barauna, Valerio Garrone and Sandrim, Valeria Cristina},
title = {Second‐trimester multimetabolite panel for early preeclampsia rule‐out},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
volume = {174},
number = {3},
pages = {1644--1654},
doi = {10.1002/ijgo.70983}
}
EUVIMED